ReBlood Rx

United States | Human Resilience & Biotechnology

Team: 10-50 Funding: Private

Reliable oxygen delivery when blood is not an option

NATO DIANA 2026 Cohort

📄

Company Overview

Country: United States

Challenge Area: Human Resilience & Biotechnology

Team Size: 10-50

Funding: Private

Reliable oxygen delivery when blood is not an option

NATO DIANA 2026 Cohort

AUXSYS Aboa Space Research Oy Avivo Biomedical Inc. Beyond Blood Diagnostics Biocellis Cohesys Deep Breathe Inc. Elitac Wearables GutSee Health Herges Detection GmbH